Evaluation of novel gene UCA1 as a tumor biomarker for the detection of bladder cancer

National Medical Journal of China

Volumn 92, Issue 6, 2012, Pages 384-387

  Zhang, Zheng ^a   Hao, Han ^a   Zhang, Cui Jian ^a   Yang, Xin Yu ^a   He, Qun ^a   Lin, Jian ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Tumor markers, biological; Urinary bladder neoplasms; Urothelial carcinoma antigen 1

Indexed keywords

BIOLOGICAL MARKER; NUCLEAR MATRIX PROTEIN 22; TUMOR ANTIGEN; UNCLASSIFIED DRUG; UROTHELIAL CARCINOMA ANTIGEN 1;

ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER INVASION; CONTROLLED STUDY; CYTOLOGY; GENE EXPRESSION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SENSITIVITY AND SPECIFICITY; URINE SEDIMENT;

CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; HUMANS; RNA, LONG UNTRANSLATED; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84867862596     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2012.06.008     Document Type: Article

References (13)

1. 2004, 23: 555-558.
2. Lotan Y, Svatek R S, Sagalowsky A I. Should we screen for bladder cancer in a high risk population? A cost per life-year saved analysis. Cancer, 2006, 107: 982-990.
3. van Rhijn B W, van der Poel H G, van der Kwast T H. Urine markers for bladder cancer surveillance: a systematic review. Eur Urol, 2005, 47: 736-748.
4. Budman L I, Kassouf W, Steinberg J R. Biomarkers for detection and surveillance of bladder cancer. Can Urol Assoc J, 2008, 2: 212-221.
5. Wang X S, Zhang Z, Wang H C, et al. Rapid identification of UCAl as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res, 2006, 12: 4851-4858.
6. Ding R, Li B, Muthukumar T, et al. CD103 mRNA levels in urinary cells predict acute rejection of renal allografts. Transplantation, 2003, 75: 1307-1312.
7. Chan R W, Tarn L S, Li E K, et al. Inflammatory cytokine gene expression in the urinary sediment of patients with lupus nephritis. Arthritis Rheum, 2003, 48: 1326-1331.
8. de Kok J B, Verhaegh G W, Roelofs R W, et al. DD3 (PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res, 2002, 62: 2695-2698.
9. Xie X Y, Yang X, Zhang J H, et al. Analysis of hTERT expression in exfoliated cells from patients with bladder transitional cell carcinomas using SYBR green real-time fluorescence quantitative PCR. Ann Clin Biochem, 2007, 44: 523-528.
10. Guo B, Luo C, Xun C, et al. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR. Exp Oncol, 2009, 31: 43-47.
11. Retz M, Lehmann J, Amann E, et al. Mucin 7 and cytokeratin 20 as new diagnostic urinary markers for bladder tumor. J Urol, 2003, 169: 86-89.
12. Singh R, Recinos R F, Agresti M, et al. Real-time reverse transcriptase polymerase chain reaction: an improvement in detecting mRNA levels in mouse cranial tissue. Plast Reconstr Surg, 2006, 117: 2227-2234.
13. Bostwick D G, Gould V E, Qian J, et al. Prostate cancer detected by uPM3: radical prostatectomy findings. Mod Pathol, 2006, 19: 630-633.